In advanced PCa, BRCA2 (7–13%), BRCA1 (0–1%), ATM (5–7%), and CDK12 (4–6%) exhibit frequent mutations [36,51,52,95]. The gene discussed is BRCA2; the disease is posterior cortical atrophy.